Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Untreated B-CLL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02135133
What this trial is testing

Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Dana-Farber Cancer Institute 27
Early research (Phase 1)UnknownNCT04691765
What this trial is testing

Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients

Who this might be right for
Chronic Lymphocytic Leukemia
Dr. David Spaner 12
Testing effectiveness (Phase 2)Ended earlyNCT01805037
What this trial is testing

Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+114 more
Northwestern University 20
Not applicableUnknownNCT01862445
What this trial is testing

Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients

Who this might be right for
CLLB-cellSmall Lymphocytic Lymphoma+2 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 100
Testing effectiveness (Phase 2)Looking for participantsNCT06849713
What this trial is testing

Zanubrutinib, Obinutuzumab, Sonrotoclax (BOSon) or BGB-16673, Obinutuzumab, Sonrotoclax (DOSon) in TN CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma (SLL)
Massachusetts General Hospital 80
Large-scale testing (Phase 3)UnknownNCT04578613
What this trial is testing

ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Beijing InnoCare Pharma Tech Co., Ltd. 218
Large-scale testing (Phase 3)Looking for participantsNCT07321652
What this trial is testing

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia
Alliance for Clinical Trials in Oncology 466
Not applicableUnknownNCT03529227
What this trial is testing

Gazyva Infusion Reaction Investigation

Who this might be right for
Chronic Lymphocytic Leukemia
Healthy Future 104
Not applicableActive Not RecruitingNCT05999877
What this trial is testing

PICAROS - Acalabrutinib RWE on 1L CLL in Spain

Who this might be right for
Chronic Lymphocytic Leukemia
AstraZeneca 192
Large-scale testing (Phase 3)Looking for participantsNCT05197192
What this trial is testing

A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 202
Not applicableStudy completedNCT00897767
What this trial is testing

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

Who this might be right for
LeukemiaLymphoma
Eastern Cooperative Oncology Group 1,873
Early research (Phase 1)Study completedNCT00006362
What this trial is testing

PS-341 in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Mayo Clinic
Early research (Phase 1)Study completedNCT00042900
What this trial is testing

Pyroxamide in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT02950051
What this trial is testing

Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 926
Testing effectiveness (Phase 2)Study completedNCT02689141
What this trial is testing

Sequential Regimen of Bendamustin-Debulking Followed by Ofatumumab and Ibrutinib in CLL Patients (CLL2-BIO)

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 66
Early research (Phase 1)Looking for participantsNCT05943496
What this trial is testing

Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia
OHSU Knight Cancer Institute 27
Testing effectiveness (Phase 2)Study completedNCT01263704
What this trial is testing

MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 42
Not applicableStudy completedNCT00445952
What this trial is testing

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 304
Early research (Phase 1)Study completedNCT00003331
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
NYU Langone Health 30
Large-scale testing (Phase 3)Active Not RecruitingNCT02048813
What this trial is testing

Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
AnemiaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
National Cancer Institute (NCI) 529
Next Page